Matinas BioPharma Hldgs (NYSEMKT:MTNB) just reported results for the first quarter of 2024. Matinas BioPharma Hldgs reported earnings per share of -3 cents. This met the analyst estimate for EPS of -3 cents. The company did not report any revenue for the quarter. InvestorPlace Earnings is a project that leverages data from TradeSmith to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up t ...